Hot or Cold

STNE stock sentiment todayStoneCo Ltd.

Sentiment verdict

Gossip first, financials second — NEUTRAL at 75% confidence.

Last updated · cached analysis, refreshes periodically

NASDAQ

STNE

StoneCo Ltd.
7.75 USD▼ 0.77%vs. session open
After hours · market closedQuote as of Nov 1, 08:25 AM UTC
NEUTRAL75% confidenceSign in to save

A fundamental powerhouse trapped in a 'cheap for a reason' cycle due to Brazilian macro volatility and management transitions.

Analyzed Oct 31, 2026, 11:23 PM UTC·Quote: CNBC / Yahoo Finance·News: Google News·Targets: StockAnalysis.com·AI: Lovable AI (google/gemini-3-flash-preview)
Tone“STNE is NEUTRAL — A fundamental powerhouse trapped in a 'cheap for a reason' cycle due to Brazilian macro volatility and management transitions. 6-month call: USD8.09 (+4.4%).”
6-month price prediction
USD8.09▲ 4.4%by May 2027
46% model confidence
Bear USD4.36Now USD7.75Bull USD11.82
Crowd call · 6 months
No predictions yet

Pick a name and you can add your own 1-, 3- and 6-month price calls — no account needed. The needle above shows where the crowd sits. Calls lock 48 hours after you make them, so every scorecard stays honest.

Make your call as a guest

You'll show up on boards and The Floor under this name. Add an email later to keep your history.

No account needed. You can add an email later to keep your calls.

Already have an account? Sign in

🔒 Full prediction model breakdown

See exactly how analyst targets, gossip sentiment and momentum are weighted into this 6-month forecast.

Sign in to go Pro →

Full model breakdown (analyst / gossip / momentum weights) is a Pro feature. Modelled for STNE. Not financial advice.

02·a

Price · last 12 months

7.75 – 19.04 USD
Growth
1W
-32.5%
1M
-17.0%
3M
-31.7%
6M
-28.5%
YTD
-47.2%
1Y
-59.2%
01

Gossip

mixed

The narrative is dominated by 'Brazil fatigue' and the aftermath of a massive multi-year de-rating. While value investors highlight strong earnings growth, the broader market is skeptical of the long-term impact of its CEO transition and the competitive threat from the Pix instant-payment system.

  • ·Monetary policy uncertainty in Brazil (SELIC rates)
  • ·Adoption of Pix cannibalizing traditional TPV (Total Payment Volume)
  • ·Recent executive leadership changes and strategy shifts
  • ·Perceived lack of a catalyst to bridge the gap between price and intrinsic value
02

Financial

strong

StoneCo displays impressive profitability recovery with expanding net margins and a robust balance sheet, though top-line growth is cooling from its hyper-growth phase.

  • ·Forward P/E under 8x, significantly below historical averages
  • ·Double-digit Adjusted Net Income growth
  • ·Strong cash position with active share buyback programs
  • ·Expanding Take Rate (approx. 2.5%+) despite competitive pressures
02b

Conviction

Mixed

Whose money is actually in the stock — insider open-market trades and the patience of the institutional holder base.

47conviction score / 100

Mixed conviction — no decisive signal from insiders or the holder base.

  • ·Insiders sold a net $208K on the open market in the last 120 days.
Insider buys (120d)
0
Net insider flow
-$208K
Patient capital
43%
🔒 Who bought, and who's holding

Pro shows every named insider trade in the window (buyer, title, size, price, and whether it was a pre-scheduled 10b5-1 sale) plus the full holder register split into patient capital and fast money.

Unlock with Pro →

Source: SEC EDGAR Form 4 + 13F holder register. Option exercises, grants, gifts and tax withholding are excluded — only open-market purchases and sales count. Not financial advice.

03

Risks

watch
  • ·Regulatory changes from the Central Bank of Brazil regarding revolving credit and interchange fees
  • ·Currency devaluation of the Brazilian Real (BRL) against the USD
  • ·Increased competition from incumbent banks and fintechs like PagSeguro
05

Analyst price target

HOT
13.34 USD▲ 72.1% vs current

Consensus average of 9 analysts · median 13.00

Low 9.00High 19.00

Source: StockAnalysis.com · updated 2026-10-30

AI-generated analysis for informational purposes only. Not financial advice.